Performance

ELVN +192.40%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
ELVN	+4.29%	+234.74%	+192.40%	—	-38.97%	1.68	0.00%

Summary

ELVN at a glance

ELVN returned +192.40% over the past year. Its worst drop in that year was -38.97%, smaller than 39% of stocks on Redstone, and its Sharpe ratio of 1.68 beats 95% of stocks on Redstone. It pays no dividends.

Ranking

How ELVN ranks

Current Drawdown

-15.70%

Rolling Volatility

58.99%

Actions

Metrics

Risk Indicators

Alpha120.40%

Beta1.12x

Sharpe1.68

Sortino3.66

Omega1.42

Calmar4.94

Martin8.60

Profile

About ELVN

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics.

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $3.8B
Listed: Feb 2023
Employees: 67
Headquarters: Burlingame, CA
Website: enliventherapeutics.com

Comparisons

ELVN: Enliven Therapeutics, Inc.

ELVN at a glance

How ELVN ranks

Current Drawdown

Rolling Volatility

About ELVN

Related comparisons